PE Fund Investments

Goldman Sachs in talks to invest $350-M in PharmEasy

Economic Times  

Goldman Sachs is in advanced talks to invest about $350 million (Rs 2,700 crore) in API Holdings, the parent of online pharmacy PharmEasy, in a structured debt transaction. The debt will carry an interest rate of 14-15% and also have a pre-agreed equity upside. The money will predominantly be used to refinance the debt the company had taken to fund its acquisition of diagnostics chain Thyrocare last year.

Want to receive such news items in your inbox? Click Here to sign up for a trial.

2021 © TSJ Media Pvt Ltd. All rights reserved.